TrialBritish journal of cancer2015

A phase II and pharmacodynamic study of sunitinib in relapsed/refractory oesophageal and gastro-oesophageal cancers.

C Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.